Santander, Spain: Subjects with a history of cannabis use are less likely than abstainers to…
Search Results for: liver disease
Cannabis use is not linked to either hepatic fibrosis or non-alcoholic fatty liver disease (NAFLD).
Cannabis use appears to be protective against liver disease progression in subjects who frequently consume alcohol.
Adults with a history of cannabis use are less likely to suffer from non-alcoholic fatty liver disease
Adults with a history of cannabis use are less likely to suffer from non-alcoholic fatty liver disease (NAFLD) than are those who have not used the substance, according to data published online in the journal PLoS One. “Active marijuana use provided a protective effect against NAFLD independent of known metabolic risk factors,” authors determined. “[W]e conclude that current marijuana use may favorably impact the pathogenesis of NAFLD in US adults.”
Cannabis may be protective against liver disease
Subjects who consume cannabis are significantly less likely to suffer from non-alcoholic fatty liver disease (NAFLD) as compared to those who do not…
Montreal, Canada: Marijuana smoking is not associated with the promotion of liver disease in subjects…